KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Clorox (CLX) EBITDA Margin (2016 - 2025)

Clorox (CLX) has 17 years of EBITDA Margin data on record, last reported at 25.76% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 1603.0% year-over-year to 25.76%; the TTM value through Dec 2025 reached 22.4%, up 843.0%, while the annual FY2025 figure was 27.7%, 296.0% up from the prior year.
  • EBITDA Margin reached 25.76% in Q4 2025 per CLX's latest filing, up from 20.36% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 30.64% in Q2 2024 and bottomed at 10.81% in Q1 2023.
  • Average EBITDA Margin over 5 years is 12.02%, with a median of 10.42% recorded in 2022.
  • Peak YoY movement for EBITDA Margin: tumbled -2192bps in 2023, then skyrocketed 1891bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 3.84% in 2021, then surged by 74bps to 6.71% in 2022, then skyrocketed by 73bps to 11.61% in 2023, then dropped by -16bps to 9.73% in 2024, then surged by 165bps to 25.76% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 25.76% in Q4 2025, 20.36% in Q3 2025, and 29.98% in Q2 2025.